Kim S et al. |
Synthesis of 15R-PGD2: a potential DP2 receptor agonist. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:15780624
|
Marshall JC |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? |
2005 |
Intensive Care Med |
pmid:15782317
|
Gazi L et al. |
Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. |
2005 |
Prostaglandins Other Lipid Mediat. |
pmid:15789622
|
Soares AF et al. |
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16198309
|
Yuhas Y et al. |
Involvement of prostaglandins in an animal model of Shigella-related seizures. |
2005 |
J. Neuroimmunol. |
pmid:16139898
|
Hatoum OA et al. |
Novel mechanism of vasodilation in inflammatory bowel disease. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141408
|
Shibata T and Uchida K |
[Current opinions on prostaglandin J2]. |
2005 |
Seikagaku |
pmid:16241007
|
Appel S et al. |
PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. |
2005 |
Blood |
pmid:16105976
|
Boyce JA |
Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. |
2005 |
Chem Immunol Allergy |
pmid:16107763
|
Hata AN et al. |
Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. |
2005 |
J. Biol. Chem. |
pmid:16030019
|
Andrews WJ et al. |
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. |
2005 |
J. Steroid Biochem. Mol. Biol. |
pmid:15862961
|
Allred CD and Kilgore MW |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. |
2005 |
Mol. Cell. Endocrinol. |
pmid:15866424
|
Marzocco S et al. |
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. |
2005 |
Intensive Care Med |
pmid:15868139
|
Capobianco E et al. |
15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism. |
2005 |
Reprod. Fertil. Dev. |
pmid:15899154
|
Avis I et al. |
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. |
2005 |
Cancer Res. |
pmid:15899809
|
Lappas M et al. |
Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. |
2004 Sep-Oct |
Placenta |
pmid:15450387
|
Kumar AP et al. |
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. |
2004 |
J. Biol. Chem. |
pmid:14668325
|
Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Itoh K et al. |
Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). |
2004 |
Mol. Cell. Biol. |
pmid:14673141
|
Kasim-Karakas SE et al. |
Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:14764771
|
Hirai H |
[Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. |
2004 |
Nippon Yakurigaku Zasshi |
pmid:14695454
|
Uehara Y |
[PGD(2)/L-PGDS system in hypertension and renal injury]. |
2004 |
Nippon Yakurigaku Zasshi |
pmid:14695455
|
Miwa Y et al. |
Physiology and pharmacology of the prostaglandin J2 family. |
2004 |
Nippon Yakurigaku Zasshi |
pmid:14695456
|
Fernández-Tome M et al. |
COX-2-mediated PGD2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue. |
2004 |
Biochem. Pharmacol. |
pmid:14698037
|
Matsuo T et al. |
15d-PGJ2 inhibits oxidized LDL-induced macrophage proliferation by inhibition of GM-CSF production via inactivation of NF-kappaB. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14741709
|
Józkowicz A et al. |
Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14715242
|
Neuhofer W et al. |
Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats. |
2004 |
Kidney Int. |
pmid:14717913
|
Ward JE et al. |
PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. |
2004 |
Br. J. Pharmacol. |
pmid:14718259
|
Ray DM et al. |
Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands. |
2004 |
Clin. Immunol. |
pmid:15451478
|
Józkowicz A et al. |
15-deoxy-delta12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15560113
|
Abraha D et al. |
(S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. |
2004 |
Int. Arch. Allergy Immunol. |
pmid:15031612
|
Rodway HA et al. |
Lysophosphatidic acid attenuates the cytotoxic effects and degree of peroxisome proliferator-activated receptor gamma activation induced by 15-deoxyDelta12,14-prostaglandin J2 in neuroblastoma cells. |
2004 |
Biochem. J. |
pmid:15171682
|
Morii E and Oboki K |
MITF is necessary for generation of prostaglandin D2 in mouse mast cells. |
2004 |
J. Biol. Chem. |
pmid:15375155
|
Kumagai M et al. |
15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells. |
2004 |
Tohoku J. Exp. Med. |
pmid:14998300
|
Emi M and Maeyama K |
The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. |
2004 |
Biochem. Pharmacol. |
pmid:15013841
|
Waits PS et al. |
Nociceptin/orphanin FQ modulates human T cell function in vitro. |
2004 |
J. Neuroimmunol. |
pmid:15020071
|
Azuma Y et al. |
Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1. |
2004 |
J. Pharmacol. Sci. |
pmid:15037811
|
Woolhiser MR et al. |
Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. |
2004 |
Clin. Immunol. |
pmid:15003814
|
Relic B et al. |
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. |
2004 |
J. Biol. Chem. |
pmid:15004016
|
Angeli V et al. |
Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. |
2004 |
J. Immunol. |
pmid:15004188
|
Lupi R et al. |
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. |
2004 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:14625208
|
Ishii T and Uchida K |
Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. |
2004 |
Chem. Res. Toxicol. |
pmid:15487891
|
Li Z et al. |
Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? |
2004 |
J. Neurosci. Res. |
pmid:15523637
|
Liu JD et al. |
Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. |
2004 |
Life Sci. |
pmid:14998722
|
Sabichi AL et al. |
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533896
|
Subbarayan V et al. |
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. |
2004 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:15533897
|
Eucker J et al. |
Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma. |
2004 |
Anticancer Drugs |
pmid:15514564
|
Yoshida M et al. |
Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15519494
|
Giri S et al. |
The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. |
2004 |
J. Immunol. |
pmid:15470065
|
Hayaishi O et al. |
Genes for prostaglandin d synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep. |
2004 |
Arch Ital Biol |
pmid:15493554
|
Emmans VC et al. |
Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. |
2004 |
Biochem. Soc. Trans. |
pmid:15494029
|
Huang H et al. |
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. |
2004 |
Mol. Cancer Res. |
pmid:15498928
|
Asami-Miyagishi R et al. |
Expression and function of PPARgamma in rat placental development. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14766236
|
Hayashi N et al. |
Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma. |
2004 |
Int. J. Oncol. |
pmid:14654945
|
Higashihara H et al. |
Hypoxia-reoxygenation enhances interleukin-8 production from U937 human monocytic cells. |
2004 |
Redox Rep. |
pmid:15720834
|
Takagi T et al. |
A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats. |
2004 |
Redox Rep. |
pmid:15720836
|
Mix KS et al. |
Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling. |
2004 |
Mol. Pharmacol. |
pmid:14742672
|
Blázovics A et al. |
[Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. |
2004 |
Orv Hetil |
pmid:15662752
|
Trottein F et al. |
Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses. |
2004 |
Crit. Rev. Immunol. |
pmid:15663363
|
Lee KJ et al. |
Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g. |
2004 |
Exp. Mol. Med. |
pmid:15665586
|
Levonen AL et al. |
Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. |
2004 |
Biochem. J. |
pmid:14616092
|
Reddy RC et al. |
Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands. |
2004 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:14617516
|
Weber SM et al. |
PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells. |
2004 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:14600076
|
Asada K et al. |
Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. |
2004 |
Am. J. Respir. Crit. Care Med. |
pmid:14563653
|
Dugo L et al. |
15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. |
2004 |
Eur. J. Pharmacol. |
pmid:15364008
|
Li L et al. |
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. |
2004 |
J. Hepatol. |
pmid:15336443
|
Hirata Y et al. |
Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. |
2004 |
Brain Res. |
pmid:15342272
|
Grau R et al. |
Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. |
2004 |
Cancer Res. |
pmid:15289320
|
Yoshimura-Uchiyama C et al. |
Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. |
2004 |
Clin. Exp. Allergy |
pmid:15298571
|
Kielian T et al. |
S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). |
2004 |
J. Neurochem. |
pmid:15312171
|
Weber SM et al. |
PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. |
2004 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15315910
|
Szczeklik W et al. |
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. |
2004 |
J. Allergy Clin. Immunol. |
pmid:15316498
|
Siavash H et al. |
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:15316561
|
Sánchez-Gómez FJ et al. |
Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. |
2004 |
Mol. Pharmacol. |
pmid:15317873
|
Shahab R et al. |
Prostaglandins, leukotrienes and perennial rhinitis. |
2004 |
J Laryngol Otol |
pmid:15318955
|
Lim SY et al. |
15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. |
2004 |
J. Biol. Chem. |
pmid:15319433
|
Sasaguri T and Miwa Y |
Prostaglandin J2 family and the cardiovascular system. |
2004 |
Curr Vasc Pharmacol |
pmid:15320511
|
Servidei T et al. |
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. |
2004 |
Oncol. Res. |
pmid:15301425
|
Boyault S et al. |
15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. |
2004 |
FEBS Lett. |
pmid:15304320
|
Ichiki T et al. |
15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15369766
|
Schlezinger JJ et al. |
Environmental and endogenous peroxisome proliferator-activated receptor gamma agonists induce bone marrow B cell growth arrest and apoptosis: interactions between mono(2-ethylhexyl)phthalate, 9-cis-retinoic acid, and 15-deoxy-Delta12,14-prostaglandin J2. |
2004 |
J. Immunol. |
pmid:15322177
|
Si Q et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits IFN-inducible protein 10/CXC chemokine ligand 10 expression in human microglia: mechanisms and implications. |
2004 |
J. Immunol. |
pmid:15322215
|
Azuma Y et al. |
Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. |
2004 |
Pharmacology |
pmid:15240994
|
Zhang C et al. |
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. |
2004 |
J. Invest. Dermatol. |
pmid:15245439
|
Siavash H et al. |
Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. |
2004 |
Cancer Lett. |
pmid:15194221
|
Li Z et al. |
Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15194490
|
Ruiz PA et al. |
15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. |
2004 |
J. Biol. Chem. |
pmid:15199053
|
Shimomura K et al. |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15201343
|
Hawcroft G et al. |
Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. |
2004 |
Cancer Lett. |
pmid:15172124
|
Son DJ et al. |
Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. |
2004 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15172681
|
Takeshita K et al. |
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. |
2004 |
Int. Immunol. |
pmid:15173122
|
Cipollone F et al. |
Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. |
2004 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15155382
|
Ward C et al. |
Regulation of granulocyte apoptosis by NF-kappaB. |
2004 |
Biochem. Soc. Trans. |
pmid:15157161
|
Miwa Y et al. |
Involvement of clusterin in 15-deoxy-delta12,14-prostaglandin J2-induced vascular smooth muscle cell differentiation. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15158456
|
Hsu MF et al. |
Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. |
2004 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:15083266
|
Karimi K et al. |
Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. |
2004 |
Eur. J. Pharmacol. |
pmid:15063154
|
Chana RS et al. |
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. |
2004 |
Kidney Int. |
pmid:15149321
|
Garg TK and Chang JY |
15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. |
2004 |
BMC Pharmacol. |
pmid:15149553
|
Park EY et al. |
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. |
2004 |
Cancer Res. |
pmid:15150131
|
Akbiyik F et al. |
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. |
2004 |
Blood |
pmid:15130939
|